Does elevated pre-treatment plasma pd-l1 level indicate an increased tumor burden and worse prognosis in metastatic colorectal cancer?

HIGHLIGHTS

• who: Magdolna Dank and colleagues from the Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University have published the article: Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?, in the Journal: (JOURNAL) of 31/05/2022
• what: A pilot study was carried out to investigate their routine oncology usefulness in mCRC patients. This study has several limiting factors.
• how: The time-dependent modeling of data was analyzed using linear mixed-effects models (Rpackage nlme version 3.1-155). The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.